↓ Skip to main content

Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children

Overview of attention for article published in Cochrane database of systematic reviews, August 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
27 tweeters
wikipedia
1 Wikipedia page
f1000
1 research highlight platform

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
131 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children
Published in
Cochrane database of systematic reviews, August 2013
DOI 10.1002/14651858.cd000060.pub2
Pubmed ID
Authors

Benedict Griffiths, Francine M Ducharme

Abstract

There are several treatment options for managing acute asthma exacerbations (sustained worsening of symptoms that do not subside with regular treatment and require a change in management). Guidelines advocate the use of inhaled short acting beta2-agonists (SABAs) in children experiencing an asthma exacerbation. Anticholinergic agents, such as ipratropium bromide and atropine sulfate, have a slower onset of action and weaker bronchodilating effect, but may specifically relieve cholinergic bronchomotor tone and decrease mucosal edema and secretions. Therefore, the combination of inhaled anticholinergics with SABAs may yield enhanced and prolonged bronchodilation.

Twitter Demographics

The data shown below were collected from the profiles of 27 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 131 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 2%
United Kingdom 1 <1%
Colombia 1 <1%
Canada 1 <1%
Unknown 125 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 23 18%
Student > Master 20 15%
Other 19 15%
Student > Bachelor 17 13%
Unspecified 11 8%
Other 41 31%
Readers by discipline Count As %
Medicine and Dentistry 82 63%
Unspecified 16 12%
Nursing and Health Professions 11 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Agricultural and Biological Sciences 4 3%
Other 14 11%

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 October 2019.
All research outputs
#814,370
of 13,617,861 outputs
Outputs from Cochrane database of systematic reviews
#2,553
of 10,681 outputs
Outputs of similar age
#11,026
of 158,652 outputs
Outputs of similar age from Cochrane database of systematic reviews
#30
of 123 outputs
Altmetric has tracked 13,617,861 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,681 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.1. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 158,652 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 123 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.